Year: 2021

LONDON, Nov. 03, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that on October 29, 2021, the Company granted three new employees non-statutory options to purchase an aggregate of 69,800 of the Company’s ordinary shares and 4,250 restricted share units (“RSUs”), each representing the right to receive one of the Company’s ordinary shares upon vesting. The awards were granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were approved by an independent subcommittee of the remuneration committee of Freeline’s...

ATLANTA, Nov. 03, 2021 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) today announced operating results for the nine months ended September 30, 2021. Mary G. Berner, President and Chief Executive Officer of CUMULUS MEDIA, said, “Our third quarter results exceeded expectations across the board, despite the ongoing impacts of COVID-19. This performance is yet another strong example of the continuing success of our evolution from a one-dimensional radio company to a multi-dimensional, audio-first media company. We see significant and continued upside potential and multiple drivers of shareholder value, which include additional radio market recovery, several fast-growing digital business lines, attractive free cash flow conversion, a strong balance sheet...

Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of intent which contemplates a proposed acquisition of Psycheceutical, Inc. Following the closing of the anticipated acquisition, Psycheceutical would emerge as the surviving company with a name and symbol change to follow. “The closing of this acquisition marks a pivotal event that will provide Psycheceutical with the opportunity to achieve its next level of corporate growth as we advance our promising psychedelic drug delivery technologies,” said Chad Harman, Psycheceutical CEO. Completion of the transaction is subject to due diligence investigations by the relevant parties, the negotiation and execution of a definitive share exchange agreement, satisfaction of the conditions negotiated...

ARLINGTON, Va. and LONDON, Nov. 03, 2021 (GLOBE NEWSWIRE) — Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, announced today that it will participate in the following conferences: the 2021 Raymond James Insurance Conference on November 9, 2021 and the Gearing up for the New Normal: A Virtual Best Ideas Conference by MKM on November 17, 2021. Both events are virtual. Carl Hess, Willis Towers Watson’s President and Future CEO, is scheduled to present at the Raymond James Insurance Conference at 1:00 p.m. Eastern Time on November 9, 2021 and the Gearing up for the New Normal: A Virtual Best Ideas Conference at 2:30 p.m. Eastern Time on November 17, 2021. A live webcast of the conference presentations will be available at the Investor Relations section of www.willistowerswatson.com. Additionally,...